These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Kumar S; Shah JP; Bryant CS; Imudia AN; Cote ML; Ali-Fehmi R; Malone JM; Morris RT Gynecol Oncol; 2008 Aug; 110(2):125-32. PubMed ID: 18571705 [TBL] [Abstract][Full Text] [Related]
5. Disparities in treatment and survival between African American and White women with vaginal cancer. Mahdi H; Kumar S; Hanna RK; Munkarah AR; Lockhart D; Morris RT; Tamimi H; Swensen RE; Doherty M Gynecol Oncol; 2011 Jul; 122(1):38-41. PubMed ID: 21497383 [TBL] [Abstract][Full Text] [Related]
6. Incidence and survival rates for female malignant germ cell tumors. Smith HO; Berwick M; Verschraegen CF; Wiggins C; Lansing L; Muller CY; Qualls CR Obstet Gynecol; 2006 May; 107(5):1075-85. PubMed ID: 16648414 [TBL] [Abstract][Full Text] [Related]
7. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Sun M; Abdollah F; Liberman D; Abdo A; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI Cancer; 2011 Sep; 117(18):4277-85. PubMed ID: 21387261 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. Mahdi H; Swensen RE; Hanna R; Kumar S; Ali-Fehmi R; Semaan A; Tamimi H; Morris RT; Munkarah AR Br J Cancer; 2011 Aug; 105(4):493-7. PubMed ID: 21772335 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching. Chen Y; Ning Y; Zhang Q; Xie Y Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854 [TBL] [Abstract][Full Text] [Related]
10. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study. Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586 [TBL] [Abstract][Full Text] [Related]
11. Racial disparity in 30-day morbidity and mortality after surgery for ovarian cancer. Mahdi H; Jernigan A; Lockhart D; Moslemi-Kebria M; Rose PG Int J Gynecol Cancer; 2015 Jan; 25(1):55-62. PubMed ID: 25427238 [TBL] [Abstract][Full Text] [Related]
12. Racial disparities in the treatment of advanced epithelial ovarian cancer. Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782 [TBL] [Abstract][Full Text] [Related]
13. Trends in the surgical management of malignant ovarian germcell tumors. Nasioudis D; Mastroyannis SA; Latif NA; Ko EM Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791 [TBL] [Abstract][Full Text] [Related]
14. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133 [TBL] [Abstract][Full Text] [Related]
15. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328 [TBL] [Abstract][Full Text] [Related]
16. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG Am J Obstet Gynecol; 2013 Nov; 209(5):468.e1-468.e10. PubMed ID: 23891626 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors. Nasioudis D; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K Int J Gynecol Cancer; 2019 Mar; 29(3):554-559. PubMed ID: 30700566 [TBL] [Abstract][Full Text] [Related]
18. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Fuh KC; Shin JY; Kapp DS; Brooks RA; Ueda S; Urban RR; Chen LM; Chan JK Gynecol Oncol; 2015 Mar; 136(3):491-7. PubMed ID: 25455734 [TBL] [Abstract][Full Text] [Related]
19. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution. Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304 [TBL] [Abstract][Full Text] [Related]
20. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors. Wang J; Chen R; Li J; Lu X Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]